Value-based healthcare for diabetes

Better Patient Outcomes. Better Care.

Diabeter wins ValueBased Healthcare Prize

11 May 2017: Diabeter has won the Value Based Healthcare Prize 2017, an initiative by Value-Based Healthcare Center Europe. This is a recognition for the patient value-oriented approach Diabeter pursued ever since its creation in 2006. The VBHC Prize was awarded by the founder of Value-Based Healthcare, Harvard Professor Michael Porter. 

Established in 2006, Dutch clinic network Diabeter has been a pioneer in value-based diabetes care, focusing on e-health solutions, delivering individualized, comprehensive care and supporting self care management.

As a result, Diabeter patients have exemplary clinical outcomes that also have resulted in lowering costs of care, which is critial to support a sustainable reimboursement model for patients. The clinic’s percentage of children reaching the HbA1c target of less than 7.5% (58 mmol/mol) is 56%, compared to the average Dutch patient outside Diabeter of 31%, making Diabeter one of the best performing clinics in the country. Helping patients improve their HbA1c has consequently led to a lower patient hospitalization rate than that of other Dutch pediatric diabetes clinics (3% versus 8%). (Source: Zorginstituut Nederland 2014).

With over 2000 patients in 5 locations, Diabeter is one of the largest diabetes clinics in Europe. As a patient-centric integrated practice unit, providing 24/7 expert support and a modern, non-hospital environment, the Diabeter care is well regarded by our patients. On the Dutch patient federation rating barometer, Zorgkaart Nederland, the Diabeter clinic network receives an average rating of 9.5 on a 10 point scale.

The Value Agenda at Diabeter

In a value-based healthcare system, the overarching goal for providers, as well as every other stakeholder, should be to improve the value of health care for patients. Michael E. Porter, professor of strategy at Harvard Business School, defines value as “the health outcomes achieved that matter to patients relative to the cost of achieving those outcomes.” Diabeter is one of the first clinics focusing on type 1 diabetes for children and young adults to exemplify all the 6 attributes of Porter's Value Agenda.


Diabeter White Paper by The Boston Consulting Group

For more information about value-based diabetes care and how Diabeter is implementing the Value Agenda of Prof. Porter, you can download our White Paper created by The Boston Consulting Group here:

Value Based Healthcare Whitepaper (857.5 KB)  

HealthManagement: Award-Winning Diabetes Clinic with VBHC Approach

An interview published in HealthManagement with Dr. Henk Veeze, co-founder of Diabeter:

Read the full article in Health Management here. 

Connect with Diabeter and our founders

Dr Henk Veeze and Dr Henk-Jan Aanstoot, founders of Diabeter, are available for seminars or gatherings for healthcare professional organisations and institutes, to present and discuss the VBHC-model as implemented at Diabeter. For questions or requesting a meeting, please contact Judith Marinissen

About Medtronic & Diabeter

In April 2015, Medtronic acquired the Diabeter clinics. While keeping clinical decision making at Diabeter fully independent, Medtronic contributes to further advancing integrated care models for diabetes patients in the Netherlands and around the world.